雲南白藥(000538.SZ):回購價上限由不超92元/股調至不超125元/股
格隆匯12月10日丨雲南白藥(000538.SZ)公佈,公司於2020年12月10日召開第九屆董事會2020年第十二次會議,審議通過《關於調整回購股份價格上限的議案》,將回購價格上限由不超過人民幣92元/股調整為不超過人民幣125元/股。除調整股份回購價格的上限外,《關於回購公司股份以實施員工激勵計劃的回購報告書》《關於回購公司股份以實施員工激勵計劃的方案》的其他內容未發生變化。此次調整回購股份價格上限的情況無需股東大會審議。
此次回購股份上限為1670萬股,佔公司目前總股本的1.31%,回購股份下限為850萬股,佔公司目前總股本的0.67%,公司目前已回購264.2034萬股,按回購股份數量上限1670萬股和調整後的回購價格上限125元/股測算,回購資金上限不超過20億元,按回購股份數量下限850萬股和調整後的回購價格上限125元/股測算,回購資金不超過10億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.